202 related articles for article (PubMed ID: 25620688)
1. Costs and health-related quality of life of patients with cystic fibrosis and their carers in France.
Chevreul K; Berg Brigham K; Michel M; Rault G;
J Cyst Fibros; 2015 May; 14(3):384-91. PubMed ID: 25620688
[TBL] [Abstract][Full Text] [Related]
2. Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe.
Chevreul K; Michel M; Brigham KB; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():7-18. PubMed ID: 27059622
[TBL] [Abstract][Full Text] [Related]
3. Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom.
Angelis A; Kanavos P; López-Bastida J; Linertová R; Nicod E; Serrano-Aguilar P;
BMC Health Serv Res; 2015 Sep; 15():428. PubMed ID: 26416027
[TBL] [Abstract][Full Text] [Related]
4. Economic Burden And Health-Related Quality Of Life Of Patients With Cystic Fibrosis In Bulgaria.
Iskrov GG; Stefanov RS; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P;
Folia Med (Plovdiv); 2015; 57(1):56-64. PubMed ID: 26431096
[TBL] [Abstract][Full Text] [Related]
5. Social/economic costs and quality of life in patients with haemophilia in Europe.
Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Gulácsi L; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():53-65. PubMed ID: 27048374
[TBL] [Abstract][Full Text] [Related]
6. Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe.
Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():19-29. PubMed ID: 27038625
[TBL] [Abstract][Full Text] [Related]
7. The economic burden and health-related quality of life associated with systemic sclerosis in France.
Chevreul K; Brigham KB; Gandré C; Mouthon L;
Scand J Rheumatol; 2015 May; 44(3):238-46. PubMed ID: 25521915
[TBL] [Abstract][Full Text] [Related]
8. [Cystic fibrosis -- disease burden and health-related quality of life of patients and their caregivers: results of the European BURQOL-RD survey in Hungary].
Péntek M; Kosztolányi G; Melegh B; Halász A; Pogány G; Baji P; Brodszky V; Vártokné Hevér N; Boncz I; Gulácsi L
Orv Hetil; 2014 Oct; 155(42):1673-84. PubMed ID: 25305725
[TBL] [Abstract][Full Text] [Related]
9. Economic burden and health-related quality of life associated with Prader-Willi syndrome in France.
Chevreul K; Berg Brigham K; Clément MC; Poitou C; Tauber M;
J Intellect Disabil Res; 2016 Sep; 60(9):879-90. PubMed ID: 27174598
[TBL] [Abstract][Full Text] [Related]
10. Fragile X syndrome: economic burden and health-related quality of life of patients and caregivers in France.
Chevreul K; Berg Brigham K; Brunn M; des Portes V;
J Intellect Disabil Res; 2015 Dec; 59(12):1108-20. PubMed ID: 26369667
[TBL] [Abstract][Full Text] [Related]
11. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe.
Angelis A; Kanavos P; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Brodszky V; von der Schulenburg JM; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1(Suppl 1):31-42. PubMed ID: 27107597
[TBL] [Abstract][Full Text] [Related]
12. Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe.
López-Bastida J; Linertová R; Oliva-Moreno J; Posada-de-la-Paz M; Serrano-Aguilar P; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Baji P; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():99-108. PubMed ID: 27038627
[TBL] [Abstract][Full Text] [Related]
13. Cystic fibrosis: cost of illness and considerations for the economic evaluation of potential therapies.
Krauth C; Jalilvand N; Welte T; Busse R
Pharmacoeconomics; 2003; 21(14):1001-24. PubMed ID: 13129414
[TBL] [Abstract][Full Text] [Related]
14. Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe.
Kuhlmann A; Schmidt T; Treskova M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Péntek M; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():79-87. PubMed ID: 27086322
[TBL] [Abstract][Full Text] [Related]
15. Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe.
Péntek M; Gulácsi L; Brodszky V; Baji P; Boncz I; Pogány G; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Iskrov G; Schieppati A; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():89-98. PubMed ID: 27062257
[TBL] [Abstract][Full Text] [Related]
16. Understanding the costs of care for cystic fibrosis: an analysis by age and health state.
van Gool K; Norman R; Delatycki MB; Hall J; Massie J
Value Health; 2013; 16(2):345-55. PubMed ID: 23538187
[TBL] [Abstract][Full Text] [Related]
17. Social/economic costs and health-related quality of life in patients with histiocytosis in Europe.
Iskrov G; Astigarraga I; Stefanov R; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Schieppati A; Taruscio D; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():67-78. PubMed ID: 27042831
[TBL] [Abstract][Full Text] [Related]
18. Determinants of health-related quality of life in polish patients with CF - adolescents' and parents' perspectives.
Borawska-Kowalczyk U; Sands D
Dev Period Med; 2015; 19(1):127-36. PubMed ID: 26003079
[TBL] [Abstract][Full Text] [Related]
19. Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based study.
Mlčoch T; Klimeš J; Fila L; Vávrová V; Skalická V; Turnovec M; Krulišová V; Jirčíková J; Zemková D; Dědečková KV; Bílková A; Frühaufová V; Homola L; Friedmannová Z; Drnek R; Dřevínek P; Doležal T; Macek M
Eur J Health Econ; 2017 Jan; 18(1):73-82. PubMed ID: 26743971
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with changes in health-related quality of life in children with cystic fibrosis during 1-year follow-up.
van Horck M; Winkens B; Wesseling G; de Winter-de Groot K; de Vreede I; Jöbsis Q; Dompeling E
Eur J Pediatr; 2017 Aug; 176(8):1047-1054. PubMed ID: 28597092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
